The Efficacy of Mentha longifolia in the Treatment of Patients With Postprandial Distress Syndrome: A Double-Blind, Randomized Clinical Trial

Authors Information
Article Notes and Dates
To Cite : Babaeian M, Naseri M, Kamalinejad M, Ghaffari F, Emadi F, et al. The Efficacy of Mentha longifolia in the Treatment of Patients With Postprandial Distress Syndrome: A Double-Blind, Randomized Clinical Trial, Iran Red Crescent Med J. 2017 ;19(2):e34538. doi: 10.5812/ircmj.34538.
Abstract
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Brun R, Kuo B. Functional dyspepsia. Therap Adv Gastroenterol. 2010; 3(3): 145-64[DOI][PubMed]
  • 2. Chang L, Toner BB, Fukudo S, Guthrie E, Locke GR, Norton NJ, et al. Gender, age, society, culture, and the patient's perspective in the functional gastrointestinal disorders. Gastroenterology. 2006; 130(5): 1435-46[DOI][PubMed]
  • 3. Collingwood S, Witherington J. Therapeutic approaches towards the treatment of gastroinstestinal disorders. Drug News Perspect. 2007; 20(2): 139-44[PubMed]
  • 4. The Canon of Medicine 2005;
  • 5. Babaeian M, Naseri M, Kamalinejad M, Ghaffari F, Emadi F, Feizi A, et al. Herbal Remedies for Functional Dyspepsia and Traditional Iranian Medicine Perspective. Iran Red Crescent Med J. 2015; 17(11)[DOI][PubMed]
  • 6. Sahib AS. Treatment of irritable bowel syndrome using a selected herbal combination of Iraqi folk medicines. J Ethnopharmacol. 2013; 148(3): 1008-12[DOI][PubMed]
  • 7. Mikaili P, Mojaverrostami S, Moloudizargari M, Aghajanshakeri S. Pharmacological and therapeutic effects of Mentha Longifolia L. and its main constituent, menthol. Anc Sci Life. 2013; 33(2): 131-8[DOI][PubMed]
  • 8. Alamgeer MS, Jabeen Q, Bashir S, Malik MNH, Khan HU, Rahman MSU, et al. Antihypertensive and toxicity studies of aqueous methanolic extract of Mentha longifolia L. JAPS. 2013; 23(6)
  • 9. Amabeoku GJ, Erasmus SJ, Ojewole JA, Mukinda JT. Antipyretic and antinociceptive properties of Mentha longifolia Huds. (Lamiaceae) leaf aqueous extract in rats and mice. Methods Find Exp Clin Pharmacol. 2009; 31(10): 645-9[DOI][PubMed]
  • 10. Shah AJ, Bhulani NN, Khan SH, Ur Rehman N, Gilani AH. Calcium channel blocking activity of Mentha longifolia L. explains its medicinal use in diarrhoea and gut spasm. Phytother Res. 2010; 24(9): 1392-7[DOI][PubMed]
  • 11. Gul H, Abbas K, Qadir M. Gastro-protective effect of ethanolic extract of Mentha longifolia in alcohol-and aspirin-induced gastric ulcer models. Bangladesh J Pharmacology. 2015; 10(1): 241-5
  • 12. Karimian P, Kavoosi G, Amirghofran Z. Anti-inflammatory effect of Mentha longifolia in lipopolysaccharide-stimulated macrophages: reduction of nitric oxide production through inhibition of inducible nitric oxide synthase. J Immunotoxicol. 2013; 10(4): 393-400[DOI][PubMed]
  • 13. Mimica-Dukic N, Popovic M, Jakovljevic V, Szabo A, Gašic O. Pharmacological studies of Mentha longifolia phenolic extracts. II. Hepatoprotective activity. Pharmaceutical biol. 1999; 37(3): 221-4
  • 14. Ghazanfarpour M, Sadeghi R, Kiani M, Khorsand I, Saeidi M. Most Common Herbal Medicines in the Treatment of Iranian Children: A Systematic Review. Int J Ped. 2014; 2(4.3): 437-44
  • 15. Mokaberinejad R, Zafarghandi N, Bioos S, Dabaghian FH, Naseri M, Kamalinejad M, et al. Mentha longifolia syrup in secondary amenorrhea: a double-blind, placebo-controlled, randomized trials. Daru. 2012; 20(1): 97[DOI][PubMed]
  • 16. Freire RB, Borba HR, Coelho CD. Ruta graveolens L. toxicity in Vampirolepis nana infected mice. Indian J Pharmacol. 2010; 42(6): 345-50[DOI][PubMed]
  • 17. Marinova D, Ribarova F, Atanassova M. Total phenolics and total flavonoids in Bulgarian fruits and vegetables. UCTM. 2005; 40(3): 255-60
  • 18. Beketov EV, Pakhomov VP, Nesterova OV. Improved method of flavonoid extraction from bird cherry fruits. Pharmaceutical Chem J. 2005; 39(6): 316-8
  • 19. Holtmann G, Adam B, Haag S, Collet W, Grunewald E, Windeck T. Efficacy of artichoke leaf extract in the treatment of patients with functional dyspepsia: a six-week placebo-controlled, double-blind, multicentre trial. Aliment Pharmacol Ther. 2003; 18(11-12): 1099-105[PubMed]
  • 20. Drossman DA, Corazziari E, Delvaux M, Spiller R, Talley NJ, Thompson WG. Appendix B: Rome III diagnostic criteria for functional gastrointestinal disorders. Revista de gastroenterologia de Mexico. 2010; 75(4): 511
  • 21. Adibi P, Keshteli AH, Esmaillzadeh A, Afshar H, Roohafza H, Bagherian-Sararoudi R, et al. The study on the epidemiology of psychological, alimentary health and nutrition (SEPAHAN): overview of methodology. J Res Med Sci. 2012; 17
  • 22. Motamed N, Ayatollahi AR, Zare N, Sadeghi-Hassanabadi A. Validity and reliability of the Persian translation of the SF-36 version 2 questionnaire. East Mediterr Health J. 2005; 11(3): 349-57[PubMed]
  • 23. Fleiss JL. Reliability of measurement. 1986;
  • 24. Bortolotti M, Coccia G, Grossi G, Miglioli M. The treatment of functional dyspepsia with red pepper. Aliment Pharmacol Ther. 2002; 16(6): 1075-82[PubMed]
  • 25. Mayer EA, Collins SM. Evolving pathophysiologic models of functional gastrointestinal disorders. Gastroenterology. 2002; 122(7): 2032-48[PubMed]
  • 26. Mizuta Y, Shikuwa S, Isomoto H, Mishima R, Akazawa Y, Masuda J, et al. Recent insights into digestive motility in functional dyspepsia. J Gastroenterol. 2006; 41(11): 1025-40[DOI][PubMed]
  • 27. Tack J, Lee KJ. Pathophysiology and treatment of functional dyspepsia. J Clin Gastroenterol. 2005; 39(5 Suppl 3)-6[PubMed]
  • 28. Karamanolis G, Caenepeel P, Arts J, Tack J. Association of the predominant symptom with clinical characteristics and pathophysiological mechanisms in functional dyspepsia. Gastroenterology. 2006; 130(2): 296-303[DOI][PubMed]
  • 29. Mkaddem M, Bouajila J, Ennajar M, Lebrihi A, Mathieu F, Romdhane M. Chemical composition and antimicrobial and antioxidant activities of Mentha (longifolia L. and viridis) essential oils. J Food Sci. 2009; 74(7)-63[DOI][PubMed]
  • 30. Kumar S, Pandey AK. Chemistry and biological activities of flavonoids: an overview. ScientificWorldJournal. 2013; 2013: 162750[DOI][PubMed]
  • 31. Min YS, Lee SE, Hong ST, Kim HS, Choi BC, Sim SS, et al. The Inhibitory Effect of Quercetin-3-O-beta-D-Glucuronopyranoside on Gastritis and Reflux Esophagitis in Rats. Korean J Physiol Pharmacol. 2009; 13(4): 295-300[DOI][PubMed]
  • 32. Said O, Saad B, Fulder S, Khalil K, Kassis E. Weight loss in animals and humans treated with "weighlevel", a combination of four medicinal plants used in traditional arabic and islamic medicine. Evid Based Complement Alternat Med. 2011; 2011: 874538[DOI][PubMed]
  • 33. Saad RJ, Chey WD. Review article: current and emerging therapies for functional dyspepsia. Aliment Pharmacol Ther. 2006; 24(3): 475-92[DOI][PubMed]
  • 34. Miwa H, Ghoshal UC, Fock KM, Gonlachanvit S, Gwee KA, Ang TL, et al. Asian consensus report on functional dyspepsia. J Gastroenterol Hepatol. 2012; 27(4): 626-41[DOI][PubMed]
  • 35. Pasricha PJ. Desperately seeking serotonin... A commentary on the withdrawal of tegaserod and the state of drug development for functional and motility disorders. Gastroenterology. 2007; 132(7): 2287-90[DOI][PubMed]
  • 36. Qin F, Huang X, Ren P. Chinese herbal medicine modified xiaoyao san for functional dyspepsia: meta-analysis of randomized controlled trials. J Gastroenterol Hepatol. 2009; 24(8): 1320-5[DOI][PubMed]
  • 37. Hohenester B, Ruhl A, Kelber O, Schemann M. The herbal preparation STW5 (lberogast) has potent and region-specific effects on gastric motility. Neurogastroenterol Motil. 2004; 16(6): 765-73[DOI][PubMed]
  • 38. Ottillinger B, Storr M, Malfertheiner P, Allescher HD. STW 5 (Iberogast(R))--a safe and effective standard in the treatment of functional gastrointestinal disorders. Wien Med Wochenschr. 2013; 163(3-4): 65-72[DOI][PubMed]
  • 39. Bahmani M, Zargaran A, Rafieian-Kopaei M. Identification of medicinal plants of Urmia for treatment of gastrointestinal disorders. Revista Brasileira de Farmacognosia. 2014; 24(4): 468-80
  • 40. Liu JH, Chen GH, Yeh HZ, Huang CK, Poon SK. Enteric-coated peppermint-oil capsules in the treatment of irritable bowel syndrome: a prospective, randomized trial. J Gastroenterol. 1997; 32(6): 765-8[PubMed]
  • 41. Wagner H. Multitarget therapy--the future of treatment for more than just functional dyspepsia. Phytomedicine. 2006; 13 Suppl 5: 122-9[DOI][PubMed]
  • 42. Aro P, Talley NJ, Agreus L, Johansson SE, Bolling-Sternevald E, Storskrubb T, et al. Functional dyspepsia impairs quality of life in the adult population. Aliment Pharmacol Ther. 2011; 33(11): 1215-24[DOI][PubMed]
  • 43. Van Oudenhove L, Vandenberghe J, Vos R, Fischler B, Demyttenaere K, Tack J. Abuse history, depression, and somatization are associated with gastric sensitivity and gastric emptying in functional dyspepsia. Psychosom Med. 2011; 73(8): 648-55[DOI][PubMed]
  • 44. Valerio DA, Georgetti SR, Magro DA, Casagrande R, Cunha TM, Vicentini FT, et al. Quercetin reduces inflammatory pain: inhibition of oxidative stress and cytokine production. J Nat Prod. 2009; 72(11): 1975-9[DOI][PubMed]
  • 45. Bhutada P, Mundhada Y, Bansod K, Ubgade A, Quazi M, Umathe S, et al. Reversal by quercetin of corticotrophin releasing factor induced anxiety- and depression-like effect in mice. Prog Neuropsychopharmacol Biol Psychiatry. 2010; 34(6): 955-60[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiaion Alert via Google Reader

Cited By:

Iranian Red Crescent Medical Journal accepts terms & conditions of:

International Committee of Medical Journal Editors (ICMJE) Citedby Linking DOI enabled Crossref iThenticate COPE Cross Check